VC  RiverVest Venture Partners

     Office Locations:

101 S. Hanley Road
Suite 1850
St. Louis, MO 63105
Phone: 314-726-6700
Fax: 314-726-6715

Get all office locations for this firm with a National Database subscription.


  • Early
  • Expansion
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Founded in September 2000, RiverVest Venture Partners has focused exclusively on innovations in life sciences. The firm identifies, found, and actively incubate promising life sciences companies, particularly in the medical device and biopharmaceutical industries. RiverVest provides practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward. RiverVest also invests in select later-stage life science companies to diversify risk and maximize portfolio returns. Since its inception, RiverVest has raised two investment funds with total committed capital of $164 million, and supported more than 25 innovated life science companies.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Andrew B. Craig Special Limited Partner
    Jay W. Schmelter Managing Director
    John McKearn PhD Manging Director
    Karen Spilizewski Vice President
    Marilyn J. Slavich Controller


    Recent Funding Events (trailing 12 months):







      Mirum Pharmaceuticals



      Series A





      Series B





      Series B


    Portfolio companies include:

        web link

        web link

      Amplyx Pharmaceuticals
        web link

      Cabrellis Pharmaceuticals

      Calypso Medical Technologies
        web link

      Cameron Health
        web link

        web link

      Centerre Healthcare
        web link

      CGI Pharmaceuticals
        web link

      Conforma Therapeutics
        web link

        web link

      Excaliard Pharmaceuticals
        web link

      Genoa Pharmaceuticals
        web link

      Idev Technologies
        web link

        web link

        web link

      Lumena Pharmaceuticals
        web link

      Luminous Medical
        web link

        web link

      Lyric Pharmaceuticals
        web link

        web link

      Mirum Pharmaceuticals
        web link

      Mpex Pharmaceuticals
        web link

      Neuros Medical
        web link

        web link

        web link

      Salient Surgical Technologies
        web link

      Securus Medical Group

      Tioma Therapeutics
        web link

      Tryton Medical
        web link

        web link

        web link

        web link

      ZS Pharma
        web link


    Recent News: